11th Feb 2025 A plain language summary of a study on long-term outcomes in IgA nephropathy patients from the UK Rare Kidney Diseases Registry (RaDaR)
16th Sep 2024 Plain language summary of the NefIgArd trial: Nefecon for treating patients with immunoglobulin A nephropathy